Basics Rapport Therapeutics, Inc. Common Stock IPO Date: June 7, 2024 Sector: Healthcare Industry: Biotech Market Cap: $524.84M Activated in VL: True Average Daily Range Avg Daily Range: $0.82 | 4.87% Avg Daily Range (30 D): $0.49 | 3.75% Avg Daily Range (90 D): $0.47 | 4.38% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): .11M Avg Daily Volume (90 D): .13M Trade Size Avg Trade Size (Sh.): 54 Avg Trade Size (Sh.) (30 D): 57 Avg Trade Size (Sh.) (90 D): 56 Institutional Trades Total Inst.Trades: 59 Avg Inst. Trade: $1.88M Avg Inst. Trade (30 D): $1.02M Avg Inst. Trade (90 D): $1.3M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.99M Avg Closing Trade (30 D): $1.08M Avg Closing Trade (90 D): $1.98M Avg Closing Volume: 189.64K     News Jun 12, 2025 @ 8:22 PM Analysts Can't Get Enough of These Little-Known Bi... Source: Marketbeat.Com Jun 2, 2025 @ 6:45 PM Rapport Therapeutics Hosts Investor and Analyst Da... Source: Rapport Therapeutics, Inc. Mar 21, 2025 @ 11:00 AM Rapport Therapeutics to Present Data at the 2025 A... Source: N/A Jan 9, 2025 @ 12:00 PM Rapport Therapeutics Announces New Phase 1 Data, F... Source: N/A Sep 5, 2024 @ 11:00 AM Rapport Therapeutics to Present at Upcoming Epilep... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3 $-.68 $-.12 Diluted EPS $-3 $-.68 $-.12 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -79.7M $ -24.06M $ -19.98M Operating Income / Loss $ -93.07M $ -27.11M $ -23.52M Cost of Revenue $ $ $ Net Cash Flow $ -16.66M $ .8M $ 17.49M PE Ratio